1. Home
  2. AVX vs ORMP Comparison

AVX vs ORMP Comparison

Compare AVX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AVX

Avax One Technology Ltd.

N/A

Current Price

$1.68

Market Cap

119.2M

Sector

Industrials

ML Signal

N/A

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$3.32

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVX
ORMP
Founded
2017
2002
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.2M
117.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
AVX
ORMP
Price
$1.68
$3.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
177.3K
292.4K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
7.27%
EPS Growth
N/A
838.25
EPS
N/A
1.03
Revenue
$1,319,011.00
$2,000,000.00
Revenue This Year
$530,767.50
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.35
Revenue Growth
8001.54
N/A
52 Week Low
$1.12
$1.82
52 Week High
$25.38
$3.71

Technical Indicators

Market Signals
Indicator
AVX
ORMP
Relative Strength Index (RSI) N/A 55.25
Support Level N/A $3.35
Resistance Level N/A $3.65
Average True Range (ATR) 0.00 0.21
MACD 0.00 -0.00
Stochastic Oscillator 0.00 56.82

Price Performance

Historical Comparison
AVX
ORMP

About AVX Avax One Technology Ltd.

AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: